Funder: NOVO NORDISK PHARMA, S.A.
date_range Duration: from 01 September 2024 to 31 December 2024 (4 months) Finished
euro 25,000.00 EUR

Of National scope. With a Private character.

Call: (NOVO NORDISK PHARMA, S.A.)

Researchers